These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37975128)

  • 1. Assessment of quality of life in patients with permanent hypoparathyroidism receiving conventional treatment.
    Cherchir F; Oueslati I; Yazidi M; Chaker F; Chihaoui M
    J Diabetes Metab Disord; 2023 Dec; 22(2):1617-1623. PubMed ID: 37975128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term complications of permanent hypoparathyroidism in adults: prevalence and associated factors.
    Cherchir F; Oueslati I; Yazidi M; Chaker F; Mizouni H; Feki M; Chihaoui M
    Endocrine; 2024 Jun; 84(3):1164-1171. PubMed ID: 38460072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal complications and quality of life in postsurgical hypoparathyroidism: a case-control study.
    Mazoni L; Matrone A; Apicella M; Saponaro F; Borsari S; Pardi E; Cosci B; Biagioni I; Rossi P; Pacciardi F; Scionti A; Elisei R; Marcocci C; Cetani F
    J Endocrinol Invest; 2022 Mar; 45(3):573-582. PubMed ID: 34637114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial.
    Khan AA; Rubin MR; Schwarz P; Vokes T; Shoback DM; Gagnon C; Palermo A; Marcocci C; Clarke BL; Abbott LG; Hofbauer LC; Kohlmeier L; Pihl S; An X; Eng WF; Smith AR; Ukena J; Sibley CT; Shu AD; Rejnmark L
    J Bone Miner Res; 2023 Jan; 38(1):14-25. PubMed ID: 36271471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTH level might be associated with impaired quality of life in patients with nonsurgical hypoparathyroidism.
    Song A; Chen S; Yang Y; Jiang Y; Jiang Y; Li M; Xia W; Wang O; Xing X
    J Endocrinol Invest; 2023 Dec; 46(12):2471-2479. PubMed ID: 37266827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTH 1-34 Replacement Therapy Has Minimal Effect on Quality of Life in Patients With Hypoparathyroidism.
    Roszko KL; Hu TY; Guthrie LC; Brillante BA; Smith M; Collins MT; Gafni RI
    J Bone Miner Res; 2022 Jan; 37(1):68-77. PubMed ID: 34585778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal parathyroid hormone levels do not exclude permanent hypoparathyroidism after thyroidectomy.
    Promberger R; Ott J; Kober F; Karik M; Freissmuth M; Hermann M
    Thyroid; 2011 Feb; 21(2):145-50. PubMed ID: 21190447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTH(1-34) for Surgical Hypoparathyroidism: A 2-Year Prospective, Open-Label Investigation of Efficacy and Quality of Life.
    Palermo A; Santonati A; Tabacco G; Bosco D; Spada A; Pedone C; Raggiunti B; Doris T; Maggi D; Grimaldi F; Manfrini S; Vescini F
    J Clin Endocrinol Metab; 2018 Jan; 103(1):271-280. PubMed ID: 29099939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of Life in Hypoparathyroidism Improves With rhPTH(1-84) Throughout 8 Years of Therapy.
    Tabacco G; Tay YD; Cusano NE; Williams J; Omeragic B; Majeed R; Almonte MG; Rubin MR; Bilezikian JP
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2748-2756. PubMed ID: 30776291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life in hypoparathyroidism.
    Vokes T
    Bone; 2019 Mar; 120():542-547. PubMed ID: 30261328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
    Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H
    Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients.
    Guh JY; Chen HC; Chuang HY; Huang SC; Chien LC; Lai YH
    Am J Kidney Dis; 2002 Jun; 39(6):1245-54. PubMed ID: 12046038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTH(1-34) for Surgical Hypoparathyroidism: A Prospective, Open-Label Investigation of Efficacy and Quality of Life.
    Santonati A; Palermo A; Maddaloni E; Bosco D; Spada A; Grimaldi F; Raggiunti B; Volpe R; Manfrini S; Vescini F;
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3590-7. PubMed ID: 26196949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of vitamin D unresponsive hypoparathyroidism with multipulse subcutaneous infusion of teriparatide.
    Puig-Domingo M; Díaz G; Nicolau J; Fernández C; Rueda S; Halperin I
    Eur J Endocrinol; 2008 Nov; 159(5):653-7. PubMed ID: 18703565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypocalcemia in hospitalized patients with COVID-19: roles of hypovitaminosis D and functional hypoparathyroidism.
    Hashemipour S; Kiani S; Shahsavari P; Afshar S; Ghobadi A; Khairkhahan SMRH; Badri M; Farzam SS; Sohrabi H; Seddighi M; Bahadori R
    J Bone Miner Metab; 2022 Jul; 40(4):663-669. PubMed ID: 35641799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of patient and disease-related factors on the quality of life in patients with hypoparathyroidism.
    Hepsen S; Akhanli P; Sakiz D; Sencar ME; Ucan B; Unsal IO; Cakal E; Ozbek M
    Arch Osteoporos; 2020 May; 15(1):75. PubMed ID: 32430780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excessive decrease in serum magnesium after total thyroidectomy for Graves' disease is related to development of permanent hypocalcemia.
    Hammerstad SS; Norheim I; Paulsen T; Amlie LM; Eriksen EF
    World J Surg; 2013 Feb; 37(2):369-75. PubMed ID: 23188529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Permanent Post-thyroidectomy Hypoparathyroidism on Self-evaluation of Quality of Life and Voice: Results From the National QoL-Hypopara Study.
    Frey S; Figueres L; Pattou F; Le Bras M; Caillard C; Mathonnet M; Hamy A; Brunaud L; Lifante JC; Trésallet C; Sebag F; Menegaux F; Blanchard C; Leroy M; Mirallié E;
    Ann Surg; 2021 Nov; 274(5):851-858. PubMed ID: 34353986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Teriparatide in Patients with Hypoparathyroidism: A Prospective, Open-label Study.
    Upreti V; Somani S; Kotwal N
    Indian J Endocrinol Metab; 2017; 21(3):415-418. PubMed ID: 28553597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTH(1-84) is associated with improved quality of life in hypoparathyroidism through 5 years of therapy.
    Cusano NE; Rubin MR; McMahon DJ; Irani D; Anderson L; Levy E; Bilezikian JP
    J Clin Endocrinol Metab; 2014 Oct; 99(10):3694-9. PubMed ID: 24978675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.